Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)
14.11
-0.13 (-0.91%)
Mar 19, 2026, 12:14 PM CST
SHE:300601 Market Cap
SHE:300601 has a market cap or net worth of 15.91 billion as of March 18, 2026. Its market cap has decreased by -8.54% in one year.
Market Cap
15.91B
Enterprise Value
16.13B
Revenue
2.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
14.11
Market Cap Chart
Since February 7, 2017, SHE:300601's market cap has increased from 1.95B to 15.91B, an increase of 716.42%. That is a compound annual growth rate of 25.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 15.91B | -3.59% |
| Dec 31, 2025 | 16.50B | -13.88% |
| Dec 31, 2024 | 19.16B | -36.83% |
| Dec 29, 2023 | 30.32B | 11.35% |
| Dec 30, 2022 | 27.23B | -59.77% |
| Dec 31, 2021 | 67.70B | -43.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tonghua Dongbao Pharmaceutical | 17.43B |
| Hybio Pharmaceutical | 16.13B |
| China Resources Jiangzhong Pharmaceutical Co.,Ltd | 16.03B |
| Nanjing King-Friend Biochemical Pharmaceutical | 16.03B |
| Guobang Pharma | 16.00B |
| Guangdong Zhongsheng Pharmaceutical | 15.36B |
| Shenzhen Hepalink Pharmaceutical Group | 15.20B |
| Zhejiang Medicine | 15.12B |